18 November, 2024Cure51 Launches NHS-Approved Study With Cambridge University Hospitals and Seven Other Leading UK Oncology Institutions to Unlock Cancer Survival Secrets
18 November, 2024BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations
31 October, 2024TechBio startup Cure51 selects 10x Genomics Visium HD for new drug discovery initiative
30 October, 2024Noema Pharma announces first patients dosed in Phase 2b study with Gemlapodect (NOE-105), a first-in-class investigational therapy for Tourette Syndrome
28 October, 2024AAVantgarde Founder and CSO is elected as President of the European Society of Gene and Cell Therapy (ESGCT)